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OutcomeAbstract Introduction: Pneumonia usually connotes the infection of pulmonary parenchyma.
Pneumonia is best classiﬁed according to the setting in which it occurs i.e community acquired
pneumonia (CAP) hospital acquired or immunodeﬁciency associated. Dietary zinc deﬁciency is
widespread in developing countries. Zinc deﬁciency is related to the morbidity and mortality in
CAP.
Aims and objectives: To compare serum zinc values of community acquired pneumonia patients
with healthy controls and to see the effect of zinc levels with severity of pneumonia.
Methods and materials: A case control study involved 100 patients of community acquired
pneumonia with age and sex matched healthy controls, after getting informed consent from all sub-
jects. The serum zinc level was measured, analyzed and interpreted with regard to age, CURB-65,
comorbidity and hospital stay.
Results and observation: The mean age of patients was 59.74 years. 53 patients were males and 47
were females. Smoking history was present in 55 patients. The mean serum zinc level in patients was
89.9 lg/dl whereas in controls it was 105.65 lg/dl, which was statistically signiﬁcant. The zinc levels
were low in elderly patients and controls as compared to young ones. Mean zinc level was lower in
patients of high CURB-65 score and vice versa.
Summary: Our study revealed a deﬁnite relation of low serum levels of zinc with community
acquired pneumonia and there is deﬁnite decrease in serum zinc levels as the age increases. Consid-
ering the morbidity, mortality, hospital stay and ﬁnancial burden and to reduce the use of
antibiotics for pneumonia, especially in developing countries like ours, serum zinc levels should
be routinely measured and thereby supplemented.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Pneumonia is an inﬂammation of pulmonary parenchyma
resulting in exudative solidiﬁcation (consolidation) of
486 M.H. Bhat et al.pulmonary tissue that may be infectious or non infectious in
nature; however in medical parlance, pneumonia usually con-
notes the infection of pulmonary parenchyma [1]. From the
patient management point of view pneumonia is best classiﬁed
according to the setting in which it occurred i.e community
acquired pneumonia (CAP), hospital acquired or immunodeﬁ-
ciency associated infection.
Community acquired pneumonia is a common and major
cause of mortality and morbidity especially in developing
world. Its incidence is 20–30% in developing world com-
pared to 3–4% in developing world [2]. Risk factors for com-
munity acquired pneumonia include increasing age and
comorbid illnesses like cardiac failure, diabetes, neoplasia
and COPD.
Five decades back it was considered improbable that zinc
deﬁciency could occur and lead to any signiﬁcant clinical prob-
lems. Zinc has been shown to play an important role in the reg-
ulation of the T cell-mediated function [3–5]. Dietary zinc
deﬁciency is widespread in developing countries [6] and is often
aggravated by intercurrent acute and chronic infections [7].
Zinc is involved in numerous aspects of cellular metabolism.
It is required for the catalytic activity of approximately 100
enzymes [8–10] and it plays a role in immune function
[10,11], protein synthesis, wound healing, DNA synthesis,
and cell division [10]. Zinc also supports normal growth and
development during pregnancy, childhood, and adolescence
[12,13] and is required for proper sense of taste and smell
[14]. A daily intake of zinc is required to maintain a steady
state because the body has no specialized zinc storage system
[15].
Recently some investigators have found that zinc deﬁciency
is related to the morbidity and mortality in community
acquired pneumonia. These studies have been done in children
[16,17].
Until recently very few studies have been done to elucidate
the role and relationship of zinc with the morbidity and mor-
tality in community acquired pneumonia. Some investigators
have found that patients with normal serum zinc levels are less
likely to have infections like community acquired pneumonia
and less frequent antibiotic use [18].
Aims and objectives
1. To compare the serum zinc values of community acquired
pneumonia patients with healthy controls.
2. To see the effect of serum zinc levels with severity of
pneumonia.
Methods and materials
The study was a hospital based prospective study comprising
100 patients attending inpatient department of Sher-I-
Kashmir Institute of Medical Sciences (SKIMS), a tertiary
care institute in an urban area of Kashmir, India. For the pur-
pose of the present study, serum zinc levels were taken at the
time of admission and the CURB 65 score was evaluated at
that time. In addition demographic characteristics, comorbidi-
ties, clinical features, vaccination status, causative agents, ther-
apy, and outcomes were noted. An informed consent was
taken from patients as well as controls.Inclusion criteria
Community acquired pneumonia was deﬁned as an acute ill-
ness (fewer than 14 days of symptoms), the presence of new
chest inﬁltrates, and clinical features suggestive of acute pneu-
monia. The clinical features required will be one of group A
(fever > 37.8 C, hypothermia < 36 C, cough and sputum pro-
duction) or two of B (dyspnea, pleuritic pain, physical ﬁndings
suggestive of lung consolidation and leukocyte count greater
than 12,000 or less than 4000). These criteria are consistent with
the published guidelines of community acquired pneumonia.
Exclusion criteria
These include:
(1) Patients with severe immunodeﬁciency as deﬁned by the
Centres for Disease Control Criteria for patients with
acquired immune deﬁciency syndrome.
(2) Patients receiving chemotherapy in the past 60 days.
(3) Patients receiving treatment with corticosteroids equiva-
lent to prednisolone at more than 20 mg/day for more
than 14 days.
(4) Patients receiving immunosuppressive drugs.
(5) Active neoplastic disease.
Other investigations
 Basic chemistry and hematology tests.
 Arterial blood gas.
 Chest radiography.
 Sputum for Gram staining and culture.
Serum zinc levels were taken from the patients of CAP.
Also samples were taken from the age and sex matched con-
trol, which were taken from the general population.
While taking blood samples for serum zinc levels in CAP
patients strict septic precautions were taken and it was made
compulsory to avoid contamination of sample. Later zinc
levels were measured by Colorimetric method with 5-Bromo-
PAPS.
Results and observation
Our study comprised 100 patients of community acquired
pneumonia. The mean age of patients was 59.74 years. From
the total number of patients 53 were males and 47 patients
were females. Smoking history was present in 55% of patients
of community acquired pneumonia. Cough was the common-
est symptom present in 89% of patients followed by breath-
lessness in 76% of patients, altered sensorium in 21% of
patients, with the least common symptom being hemoptysis
present in only 7% of CAP patients. 65% our patients had a
curb-65 score of 2–3 (Table 1). More than half of our patients
were hypertensive (55%), with COPD being present in 42% of
patients, 17% were diabetic, 6 patients were labeled as having
coronary artery disease. 7 patients were suffering from chronic
kidney disease, 2 patients were having chronic liver dis-
ease.71% of our patients had consolidation on chest X-ray,
inﬁltrates in 21 patients with 4 patients had both. Pleural
effusion was seen in 4 patients (Table 3). The mean PH value
Table 1 Basic characteristics, Clinical feature, and CURB 65
score.
Age (yrs) <40 40–60 >60
No. 06 58 36
Sex Male Female
No. 53 47
Smoking Present Absent
No 55 45
Symptom Present Absent
Cough 89 11
Breathlessness 76 24
Fever 63 37
Altered sensorium 21 79
Chest pain 13 87
Hemoptysis 7 93
CURB-65 No.
0–1 24
2–3 65
4–5 11
Table 2 CBC, biochemistry and arterial blood gases.
Variable No. Min Max Mean SD
Hemoglobin (g/dl) 100 6.2 18.6 11.9 2.36
TLC (ll) 100 1.5 24.6 11.6 4.77
Platelets 100 26.0 426.0 151.0 70.48
Urea (mg/dl) 100 16.0 272.0 79.0 47.68
Creatinine (mg/dl) 100 0.8 11.3 1.8 1.48
Bilirubin (mg/dl) 100 0.3 13.5 1.3 1.47
ALT (mg/dl) 100 7.0 714.0 89.3 131.54
Total protein (g/dl) 100 3.8 9.8 6.1 0.73
Albumin (g/dl) 100 1.9 4.3 3.1 0.50
Calcium (mg/dl) 100 6.8 10.2 8.8 0.65
LDH 100 108 2359 597.5 385.80
PH 100 7.13 7.52 7.4 0.09
PAO2 mm hg 100 26 77 56.3 9.55
PCO2 mm hg 100 19 90 42.4 14.43
SAO2% 100 46 98 84.0 11.00
Sodium (meq/l) 100 117 155 139.0 7.04
Potassium (meq/l) 100 1.7 5.4 3.5 0.73
HCO3 100 9.3 52.6 23.9 7.00
Table 3 Various comorbidities present in our patients.
Frequency Percent
Sex Male 53 53
Female 47 47
COPD Present 42 42
Absent 58 58
Diabetes Present 17 17
Absent 83 83
Hypertension Present 55 55
Absent 45 45
Coronary artery
disease
Present 6 6
Absent 94 94
Congestive heart
failure
Present 17 17
Absent 83 83
Chronic kidney
disease
Present 7 7
Absent 93 93
Chronic liver
diseases
Present 2 2
Absent 98 98
Chest X-ray Consolidation 71 71
Consolidation &
inﬁltrates
4 4
Consolidation & pleural
eﬀusion
1 1
Inﬁltrates 21 21
Inﬁltrates & pleural
eﬀusion
1 1
Pleural eﬀusion 2 2
Zinc Levels in community acquired pneumonia 487was 7.4 with mean PaO2 of 56.3 mm hg. The mean PCO2 was
42.4 mm hg with highest value being 90 mm hg (Table 2). In all
age groups the serum zinc levels in patients were lower than
those of controls. The mean serum zinc level in patients of
community acquired pneumonia was 89.9 lg/dl whereas that
of age and sex matched healthy controls was 105.65 lg/dl
which was statistically signiﬁcant. The mean serum zinc level
in patients below age of 40 years was 96.38 lg/dl and above
65 years of age was 87.04 lg/dl. There was a decreasing trend
of serum zinc levels as the age group increased. The mean
serum zinc value in healthy controls less than 40 years of age
was 118.96 lg/dl whereas those above 40 years of age had
105.05 lg/dl (Tables 4–6). The mean serum zinc level in
patients with CURB-65 score of 1 was 98.3 lg/dl whereas that
with CURB-65 score of 4 had 81.0 98.3 lg/dl. The serum zinc
level in patients having hospital stay of less than 1 week was91.0 lg/dl whereas that having more than 1 week was
89.1 lg/dl (Tables 7 and 8). There was no signiﬁcant associa-
tion between the serum zinc levels and underlying comorbidi-
ties in patients of community acquired pneumonias, although
they are independent risk factors for the CAP.
Discussion
The present study was conducted to assess the possible appli-
cation of serum zinc levels as an ancillary tool in the diagnosis
and assessment of severity of community acquired pneumonia.
The serum zinc levels were measured from community
acquired pneumonia patients. The sample was drawn as soon
as the diagnosis was suspected and only those cases were
included in whom diagnosis was conﬁrmed by radiology or
cultures.
The measured mean serum zinc level in patients of commu-
nity acquired pneumonia was 73.3 ± 10.83 lg/dl, whereas that
of controls was 98.4 ± 12.89 lg/dl. This variation is statisti-
cally highly signiﬁcant.
Only one study has been done in adults who compared
serum zinc levels in pneumonia patients. Devrajani [19] found
that mean serum zinc level was 8.279 ± 2.77 mmol/L (54.11 ±
18.1 lg/dl), while it was higher in our patients. Hypozincemia
was deﬁned as serum zinc levels of less than 11 lmol/L
(72 lg/dl). They however interpreted the measured serum zinc
levels without showing any correction with serum protein
levels. 39% of our patients also had measured serum zinc
levels 6 70 lg/dl and 78% of our patients has measured serum
zinc levels < 80 lg/dl. However the corrected serum zinc levels
were greater as most of our patients had hypoproteinemia.
Meydani [18] also found that individuals with low serum zinc
levels also had low serum albumin concentration.
Table 4 Comparison of uncorrected zinc levels (ld/dl) in cases and controls.
Age group (years) Cases Controls p-Value Remarks
No. Mean SD No. Mean SD
<40 6 80 7.38 6 107.2 13.51 0.002 Sig.
40–65 58 74.7 11.60 67 98.9 12.62 <0.001 Highly Sig.
>65 36 70.3 9.21 27 95.2 12.83 <0.001 Highly Sig.
Table 5 Corrected serum zinc levels (lg/dl).
Group No. Mean SD p-Value Remarks
Case 100 89.90 13.64 <0.001 Highly Sig.
Control 100 105.65 13.89
Table 7 Corrected zinc levels (lg/dl) on the basis of CURB-
65 score.
CURB-65
score
No. Mean SD Min Max p-Value Remarks
1 24 98.3 13.74 66.2 127.1 0.001 Sig.
2 42 90.0 13.29 54.1 120.7
3 23 85.2 10.47 72.8 112.8
4 11 81.0 11.59 62.0 106.7
Table 8 Comparing corrected zinc levels (lg/dl) depending on
hospital stay (in days).
Hospital stay No. Mean SD p-Value Remarks
<8 44 91.0 13.15 0.491 Not Sig.
P8 56 89.1 14.07
488 M.H. Bhat et al.So all our results were interpreted after correcting the zinc
values with their respective protein levels.
The calculated mean serum zinc level in patients of commu-
nity acquired pneumonia was 89.90 ± 13.64 mcg/dl, whereas
that of controls was 105.65 ± 13.89 mcg/dl. This variation is
statistically highly signiﬁcant. It established that serum zinc
levels show a deﬁnite fall in pneumonia.
The patients belonged to all the age groups ranging from 15
to 95 years. Majority of the patients were in the age group of
40–65 years (58%). 36% of patients were above 65 years of
age. Only 6% of patients were below 40 years of age.
On the other hand the control group cases were in the range
of 15–83 years with 67% in the age group of 40–65 years, 6%
below 40 years and rest above 65 years.
The age variation between cases and controls is statistically
insigniﬁcant. The calculated or corrected mean serum zinc level
in patients of community acquired pneumonia aged less than
40 years is 96.38 ± 15.75 lg/dl and that of 40–65 years is
90.98 ± 14.35 lg/dl. As the age group increased the mean
serum zinc levels decreased. The mean serum zinc level of
patients aged more than 65 years is 87.04 ± 11.74 lg/dl,
although it was not statistically signiﬁcant. Similarly the cor-
rected zinc level in controls of age group less than 40 years is
118.96 ± 6.63 lg/dl while that of 40–65 years of age is
105.05 ± 13.91 lg/dl. Controls again showed the same trend
of decreasing serum zinc levels with increasing age. The zinc
level in the age group of more that 65 years is 104
± 13.82 lg/dl. This comparison showed that values of serum
zinc level in controls in the age group of less that 40 years in
relation to the rest of the 2 groups is statistically signiﬁcant.
But comparison between 40 and 65 years age group versus
more than 65 years was not statistically signiﬁcant. While com-Table 6 Comparison of corrected zinc levels (ld/dl) in cases and c
Age group Cases Contro
No. Mean SD No.
<40 6 96.38 15.75 6
40-65 58 90.98 14.35 67
>65 36 87.04 11.74 27paring the serum zinc levels in patients (mean 96.38
± 15.75 lg/dl) in the age group of less than 40 years with cor-
responding controls (118.96 ± 6.63 lg/dl) the results were sta-
tistically signiﬁcant (p= 0.009). Similarly comparing the mean
zinc values in the age group of 40–65 years, between cases
(90.98 ± 14.35 lg/dl) and control (105.05 ± 13.91 lg/dl), the
variation is statistically highly signiﬁcant (p< 0.001).
The patients aged more than 65 years also showed a varia-
tion, when compared to age matched controls, that was highly
signiﬁcant. Their mean serum zinc levels were 98.3 ± 13.74
lg/dl (range 66.2–127.1). 42% patients had CURB-65 score
of 2 with serum zinc levels of 90.0 ± 13.29 lg/dl (range
54.1–120.7). Patients with CURB score-65 of 3 (23%) had
a mean serum zinc level of 85.2 ± 10.47 lg/dl (range
72.8–112.8) while those with score of 4 had zinc concentration
of 81 ± 11.59 lg/dl (62–106.7). The results were statistically
signiﬁcant (p value = 0.001). Devrajani also found that the
severity of hypozincemia was correlated with CURB-65 score.ontrols on the basis of age (years).
ls p-Value Remarks
Mean SD
118.96 6.63 0.009 Sig.
105.05 13.91 <0.001 Highly Sig.
104.18 13.82 <0.001 Highly Sig.
Zinc Levels in community acquired pneumonia 489The higher the CURB-65 score, the lower the serum zinc levels.
Our study also showed that the serum zinc levels decreased as
the CURB-65 score of patients increased, although our cor-
rected zinc values were higher as most of our patients had low
serum proteins due to the presence of multiple comorbidities.
In the patient group, males had slightly higher zinc values
as compared to females (90.0 ± 16.41 lg/dl versus 89.7
± 9.79 lg/dl) which was not statistically signiﬁcant. In the
control group males had a mean serum zinc level of 108.4
± 14.22 lg/dl while females had 102.5 ± 12.96 lg/dl which
was statistically signiﬁcant. Devrajani also found that males
had higher serum zinc levels as compared to females although
that was statistically insigniﬁcant. The overall mean of serum
zinc in male and female population was 9.472 ± 3.63 mmol/l
(61.89 lg/dl) and 8.130 ± 2.94 mmol/l (53.1 lg/dl) respectively
(p< 0.03). Although, multiple studies have been done in chil-
dren showing decreased serum zinc levels in pneumonia
patients as compared to age matched controls. Also various
studies have shown that the introduction of zinc in the man-
agement of pneumonia patients in children decreased duration
of severe pneumonia and hospital stay as well as mortality. But
further studies are needed to be done whether true hypoz-
incemia also occurs in adult pneumonia patients and whether
the introduction of zinc in pneumonia patients will also reduce
the hospital stay, duration of severe illness as well as mortality.
There was no signiﬁcant relation between zinc levels and asso-
ciated co-morbidities.
Summary
Our study revealed a deﬁnite relation of low serum levels of
zinc with community acquired pneumonia and there is a deﬁ-
nite decrease in serum zinc levels as the age increases. There
was no deﬁnite relation between the zinc levels, smoking and
other comorbidities, although they are independent risk fac-
tors for developing pneumonia. The level of low serum levels
is associated with severity of pneumonia and associated mor-
bidity and mortality.
Considering the morbidity, mortality, hospital stay and
ﬁnancial burden thereof in pneumonia patients especially in
developing countries like ours, serum zinc levels should be rou-
tinely measured and thereby supplemented. Although till now
studies have been predominantly performed in children which
recommended prophylactic and therapeutic administration of
zinc in children to reduce morbidity, mortality and to lessen
antibiotic use, same needs to be studied in adults also in large
studies.
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